TSE:AUP - Isotechnika Pharma Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
C$7.56 +0.03 (+0.40 %)
(As of 05/27/2018 07:34 AM ET)
Previous CloseC$7.56
Today's RangeC$7.55 - C$7.71
52-Week RangeC$5.68 - C$9.75
Volume17,200 shs
Average Volume45,474 shs
Market CapitalizationC$596.22 million
P/E RatioN/A
Dividend YieldN/A
Beta3.34

About Isotechnika Pharma (TSE:AUP)

Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company, engages in the development of a therapeutic drug to treat autoimmune diseases in Canada and internationally. The company is developing Voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis. It has partnership agreements with Paladin Labs Inc. and 3SBio, Inc. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada.

Receive AUP News and Ratings via Email

Sign-up to receive the latest news and ratings for AUP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Technical & System Software
Sub-IndustryN/A
SectorComputer and Technology
SymbolTSE:AUP
CUSIPN/A
Phone+1-250-7084272

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-45,241.38%
Return on Equity-30.41%
Return on Assets-25.82%

Miscellaneous

EmployeesN/A
Outstanding Shares84,052,000

Isotechnika Pharma (TSE:AUP) Frequently Asked Questions

What is Isotechnika Pharma's stock symbol?

Isotechnika Pharma trades on the Toronto Stock Exchange (TSX) under the ticker symbol "AUP."

How were Isotechnika Pharma's earnings last quarter?

Isotechnika Pharma Inc. (TSE:AUP) posted its quarterly earnings data on Thursday, May, 10th. The company reported ($0.23) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by $0.02. The firm had revenue of $0.04 million for the quarter, compared to analysts' expectations of $0.07 million. Isotechnika Pharma had a negative net margin of 45,241.38% and a negative return on equity of 30.41%. View Isotechnika Pharma's Earnings History.

When is Isotechnika Pharma's next earnings date?

Isotechnika Pharma is scheduled to release their next quarterly earnings announcement on Thursday, August, 9th 2018. View Earnings Estimates for Isotechnika Pharma.

Who are some of Isotechnika Pharma's key competitors?

Who are Isotechnika Pharma's key executives?

Isotechnika Pharma's management team includes the folowing people:
  • Dr. Richard M. Glickman, Founder, Chairman & CEO (Age 60)
  • Mr. Michael R. Martin, Co-Founder and Chief Operating Officer
  • Mr. Dennis Bourgeault, CFO & Sec.
  • Mr. Robert B. Huizinga RN NNC, MSc(Epi), CNeph(C), Exec. VP of Corp. Devel.
  • Dr. Neil Solomons M.D., Chief Medical Officer

Has Isotechnika Pharma been receiving favorable news coverage?

News stories about AUP stock have been trending positive on Sunday, according to Accern. The research firm identifies positive and negative press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Isotechnika Pharma earned a daily sentiment score of 0.42 on Accern's scale. They also gave media stories about the company an impact score of 46.47 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

How do I buy shares of Isotechnika Pharma?

Shares of AUP and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Isotechnika Pharma's stock price today?

One share of AUP stock can currently be purchased for approximately C$7.56.

How big of a company is Isotechnika Pharma?

Isotechnika Pharma has a market capitalization of C$596.22 million.

How can I contact Isotechnika Pharma?

Isotechnika Pharma's mailing address is 1203-4464 Markham St, VICTORIA, BC V8Z 7X8, Canada. The company can be reached via phone at +1-250-7084272.


MarketBeat Community Rating for Isotechnika Pharma (AUP)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  94 (Vote Outperform)
Underperform Votes:  75 (Vote Underperform)
Total Votes:  169
MarketBeat's community ratings are surveys of what our community members think about Isotechnika Pharma and other stocks. Vote "Outperform" if you believe AUP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AUP will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Isotechnika Pharma (TSE:AUP) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Isotechnika Pharma in the last 12 months. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Isotechnika Pharma (TSE:AUP) Consensus Price Target History

Price Target History for Isotechnika Pharma (TSE:AUP)

Isotechnika Pharma (TSE:AUP) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
10/6/2017Seaport Global SecuritiesReiterated RatingBuyView Rating Details
5/15/2017Leerink SwannReiterated RatingOutperformView Rating Details
11/4/2016Bloom BurtonReiterated RatingBuyView Rating Details
11/1/2016MackieReiterated RatingSpeculative BuyView Rating Details
(Data available from 5/27/2016 forward)

Earnings

Isotechnika Pharma (TSE:AUP) Earnings History and Estimates Chart

Earnings by Quarter for Isotechnika Pharma (TSE:AUP)

Isotechnika Pharma (TSE:AUP) Earnings Estimates

2018 EPS Consensus Estimate: ($0.96)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.25)($0.25)($0.25)
Q2 20181($0.23)($0.23)($0.23)
Q3 20181($0.23)($0.23)($0.23)
Q4 20181($0.25)($0.25)($0.25)

Isotechnika Pharma (TSE AUP) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/9/2018        
5/10/2018Q1 2018C($0.21)C($0.23)C$0.07 millionC$0.04 millionViewN/AView Earnings Details
3/15/2018Q4 2017C($0.18)C($0.05)C$0.07 millionC$0.04 millionViewN/AView Earnings Details
11/14/2017Q3 2017C($0.18)C($0.20)C$0.17 millionC$0.04 millionViewN/AView Earnings Details
8/10/2017Q2 2017C($0.17)C($0.04)C$0.08 millionC$0.44 millionViewN/AView Earnings Details
5/15/2017Q1 2017C($0.27)C$0.04 millionViewN/AView Earnings Details
3/9/2017Q4 2016C($0.29)C$0.04 millionViewN/AView Earnings Details
11/4/2016Q3 2016C($0.25)C$0.04 millionViewN/AView Earnings Details
8/5/2016Q2 2016C($0.18)C$0.07 millionViewN/AView Earnings Details
5/11/2016Q1 2016C($0.18)C$0.08 millionViewN/AView Earnings Details
3/18/2016Q4 2015C($0.21)C$0.08 millionViewN/AView Earnings Details
11/13/2015Q3 2015C($0.24)C$0.08 millionViewN/AView Earnings Details
8/11/2015Q2 2015C($0.03)C$0.07 millionViewN/AView Earnings Details
5/15/2015Q1 2015C($0.32)C$0.07 millionViewN/AView Earnings Details
3/30/2015Q4 2014C($0.19)C$0.09 millionViewN/AView Earnings Details
11/12/2014Q3 2014C($0.09)C$0.08 millionViewN/AView Earnings Details
8/14/2014Q2 2014C($0.14)C$0.08 millionViewN/AView Earnings Details
5/15/2014Q1 2014C($0.26)C$0.07 millionViewN/AView Earnings Details
3/31/2014Q4 2013C$0.12C$0.75 millionViewN/AView Earnings Details
11/21/2013Q3 2013C($0.01)C$0.09 millionViewN/AView Earnings Details
8/13/2013Q2 2013C($0.50)C$0.09 millionViewN/AView Earnings Details
4/3/2013Q4 2012C($2.00)ViewN/AView Earnings Details
11/13/2012Q3 2012C($0.50)ViewN/AView Earnings Details
8/14/2012Q2 2012C($0.50)ViewN/AView Earnings Details
5/11/2012Q1 2012C($0.15)ViewN/AView Earnings Details
3/13/2012Q4 2011C($0.60)ViewN/AView Earnings Details
11/10/2011Q3 2011C$0.65ViewN/AView Earnings Details
8/6/2011Q1 2011C($0.65)ViewN/AView Earnings Details
7/29/2011Q2 2011C$0.10ViewN/AView Earnings Details
3/25/2011Q4 2010C($1.00)ViewN/AView Earnings Details
11/9/2010Q3 2010C($0.50)ViewN/AView Earnings Details
8/11/2010Q2 2010C($0.20)ViewN/AView Earnings Details
5/12/2010Q1 2010C($0.60)ViewN/AView Earnings Details
3/24/2010Q4 2009C($0.50)ViewN/AView Earnings Details
11/11/2009Q3 2009C($0.50)ViewN/AView Earnings Details
8/6/2009Q2 2009C($0.90)ViewN/AView Earnings Details
5/14/2009Q1 2009C($1.95)ViewN/AView Earnings Details
3/27/2009Q4 2008C($2.50)ViewN/AView Earnings Details
8/6/2008Q2 2008C($2.50)ViewN/AView Earnings Details
5/6/2008Q1 2008C($2.50)ViewN/AView Earnings Details
3/19/2008Q4 2007C($4.00)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Isotechnika Pharma (TSE:AUP) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Isotechnika Pharma (TSE AUP) Insider Trading and Institutional Ownership History

Insider Trading History for Isotechnika Pharma (TSE:AUP)

Isotechnika Pharma (TSE AUP) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/12/2017Rashieda GluckInsiderBuy50C$0.10C$5.00
3/23/2016Rashieda GluckInsiderSell1,500C$3.00C$4,500.00
(Data available from 1/1/2013 forward)

Headlines

Isotechnika Pharma (TSE AUP) News Headlines

Source:
DateHeadline
Equities Analysts Offer Predictions for Isotechnika Pharma Inc.s FY2018 Earnings (AUP)Equities Analysts Offer Predictions for Isotechnika Pharma Inc.'s FY2018 Earnings (AUP)
www.americanbankingnews.com - May 17 at 8:16 AM
Edited Transcript of AUP.TO earnings conference call or presentation 10-May-18 8:30pm GMTEdited Transcript of AUP.TO earnings conference call or presentation 10-May-18 8:30pm GMT
finance.yahoo.com - May 11 at 10:38 AM
Aurinia Reports First Quarter Financial Results and Operational HighlightsAurinia Reports First Quarter Financial Results and Operational Highlights
finance.yahoo.com - May 10 at 4:27 PM
Isotechnika Pharma (AUP) Scheduled to Post Earnings on ThursdayIsotechnika Pharma (AUP) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - May 3 at 3:19 AM
Aurinia to Present at the Bloom Burton & Co. Healthcare Investor Conference on May 3, 2018Aurinia to Present at the Bloom Burton & Co. Healthcare Investor Conference on May 3, 2018
finance.yahoo.com - April 25 at 4:30 PM
Aurinia Pharmaceuticals (AUP) Given Buy Rating at Seaport Global SecuritiesAurinia Pharmaceuticals (AUP) Given Buy Rating at Seaport Global Securities
www.americanbankingnews.com - April 7 at 6:36 PM
Aurinia Announces Participation at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco on April 8-10, 2018Aurinia Announces Participation at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco on April 8-10, 2018
finance.yahoo.com - April 2 at 4:22 PM
FY2018 EPS Estimates for Aurinia Pharmaceuticals Inc Cut by Analyst (AUP)FY2018 EPS Estimates for Aurinia Pharmaceuticals Inc Cut by Analyst (AUP)
www.americanbankingnews.com - March 23 at 9:56 AM
Aurinia Pharmaceuticals Inc Forecasted to Earn Q1 2018 Earnings of ($0.25) Per Share (AUP)Aurinia Pharmaceuticals Inc Forecasted to Earn Q1 2018 Earnings of ($0.25) Per Share (AUP)
www.americanbankingnews.com - March 19 at 1:04 AM
Aurinia Reports Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights - Business Wire (press release)Aurinia Reports Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights - Business Wire (press release)
www.businesswire.com - March 17 at 4:54 PM
Edited Transcript of AUP.TO earnings conference call or presentation 15-Mar-18 8:30pm GMTEdited Transcript of AUP.TO earnings conference call or presentation 15-Mar-18 8:30pm GMT
finance.yahoo.com - March 16 at 5:14 PM
Today’s Research Reports on Aurinia Pharmaceuticals, Revive Therapeutics, Canopy Growth and Spectral MedicalToday’s Research Reports on Aurinia Pharmaceuticals, Revive Therapeutics, Canopy Growth and Spectral Medical
finance.yahoo.com - March 15 at 9:34 AM
Aurinia Pharmaceuticals (AUP) to Release Earnings on ThursdayAurinia Pharmaceuticals (AUP) to Release Earnings on Thursday
www.americanbankingnews.com - March 8 at 1:30 AM
Aurinia Enhances Research, Development, and Scientific Expertise with the Appointment of Michael Hayden to its Board of DirectorsAurinia Enhances Research, Development, and Scientific Expertise with the Appointment of Michael Hayden to its Board of Directors
finance.yahoo.com - February 22 at 4:43 PM
Today’s Research Reports on Aurinia Pharmaceuticals, Crescita Therapeutics, CanniMed Therapeutics and Titan MedicalToday’s Research Reports on Aurinia Pharmaceuticals, Crescita Therapeutics, CanniMed Therapeutics and Titan Medical
finance.yahoo.com - February 20 at 9:13 AM
Aurinia Pharmaceuticals Launches New Lupus Nephritis Disease Awareness ProgramAurinia Pharmaceuticals Launches New Lupus Nephritis Disease Awareness Program
finance.yahoo.com - February 14 at 9:03 AM
Aurinia to Present at Leerink Partners 7th Annual Global Healthcare ConferenceAurinia to Present at Leerink Partners 7th Annual Global Healthcare Conference
finance.yahoo.com - February 6 at 9:01 AM
Toronto Exchanges Stock Review, Oncolytics Biotech, Aurinia Pharmaceuticals, Immunovaccine, and IntelliPharmaCeutics InternationalToronto Exchanges Stock Review, Oncolytics Biotech, Aurinia Pharmaceuticals, Immunovaccine, and IntelliPharmaCeutics International
finance.yahoo.com - January 16 at 9:03 AM
Edited Transcript of AUP.TO earnings conference call or presentation 14-Nov-17 9:30pm GMTEdited Transcript of AUP.TO earnings conference call or presentation 14-Nov-17 9:30pm GMT
finance.yahoo.com - January 15 at 5:48 PM
Aurinia Pharmaceuticals Files New Preliminary Base Shelf Prospectus to Replace Expired Base Shelf ProspectusAurinia Pharmaceuticals Files New Preliminary Base Shelf Prospectus to Replace Expired Base Shelf Prospectus
finance.yahoo.com - January 4 at 5:50 PM
Aurinia Pharmaceuticals Inc (AUPH) Shares Dip on New Shelf RegistrationAurinia Pharmaceuticals Inc (AUPH) Shares Dip on New Shelf Registration
finance.yahoo.com - January 4 at 5:50 PM
Is Aurinia Pharmaceuticals a Buy?Is Aurinia Pharmaceuticals a Buy?
finance.yahoo.com - December 19 at 8:57 AM
Canadian Exchanges Stock Scanner Oncolytics Biotech, Aurinia Pharmaceuticals, Immunovaccine, and IntelliPharmaCeutics InternationalCanadian Exchanges Stock Scanner Oncolytics Biotech, Aurinia Pharmaceuticals, Immunovaccine, and IntelliPharmaCeutics International
finance.yahoo.com - December 14 at 9:01 AM
Aurinia Pharmaceuticals Inc (AUPH) to Enter NASDAQ Biotech IndexAurinia Pharmaceuticals Inc (AUPH) to Enter NASDAQ Biotech Index
finance.yahoo.com - December 12 at 9:23 AM
Aurinia Pharmaceuticals Added to the NASDAQ Biotech IndexAurinia Pharmaceuticals Added to the NASDAQ Biotech Index
finance.yahoo.com - December 11 at 4:16 PM
Aurinia Pharmaceuticals, Inc. :AUP-CA: Earnings Analysis: Q3, 2017 By the Numbers : November 23, 2017Aurinia Pharmaceuticals, Inc. :AUP-CA: Earnings Analysis: Q3, 2017 By the Numbers : November 23, 2017
finance.yahoo.com - November 23 at 3:38 PM
FY2017 EPS Estimates for Aurinia Pharmaceuticals Inc Cut by Cantor Fitzgerald (AUP)FY2017 EPS Estimates for Aurinia Pharmaceuticals Inc Cut by Cantor Fitzgerald (AUP)
www.americanbankingnews.com - November 22 at 5:54 AM
Brokers Issue Forecasts for Aurinia Pharmaceuticals Incs Q4 2017 Earnings (AUP)Brokers Issue Forecasts for Aurinia Pharmaceuticals Inc's Q4 2017 Earnings (AUP)
www.americanbankingnews.com - November 17 at 10:12 PM
FY2017 Earnings Estimate for Aurinia Pharmaceuticals Inc (AUP) Issued By Leerink SwannFY2017 Earnings Estimate for Aurinia Pharmaceuticals Inc (AUP) Issued By Leerink Swann
www.americanbankingnews.com - November 17 at 8:08 PM
14 Stocks Moving In Tuesdays After-Hours Session - Benzinga14 Stocks Moving In Tuesday's After-Hours Session - Benzinga
www.benzinga.com - November 15 at 2:43 AM
Aurinia Reports Third Quarter 2017 Financial Results and Provides Operational Highlights - Business Wire (press release)Aurinia Reports Third Quarter 2017 Financial Results and Provides Operational Highlights - Business Wire (press release)
www.businesswire.com - November 15 at 2:43 AM
Aurinia Pharmaceuticals Inc (AUP) Set to Announce Quarterly Earnings on TuesdayAurinia Pharmaceuticals Inc (AUP) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - November 8 at 10:14 AM
Cramers lightning round: Im concerned about GameStop ahead of the holidays - CNBCCramer's lightning round: I'm concerned about GameStop ahead of the holidays - CNBC
www.cnbc.com - November 4 at 5:46 PM
Aurinia Pharmaceuticals: R&D Day Update On Its Clinical Program And Pipeline DevelopmentAurinia Pharmaceuticals: R&D Day Update On Its Clinical Program And Pipeline Development
seekingalpha.com - October 31 at 3:12 AM
Aurinia Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : AUP-CA : October 23, 2017Aurinia Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : AUP-CA : October 23, 2017
finance.yahoo.com - October 23 at 3:57 PM
Aurinia to Expand Renal Franchise with Novel Indications and Launches Development Program for Treatment of Dry ... - Business Wire (press release)Aurinia to Expand Renal Franchise with Novel Indications and Launches Development Program for Treatment of Dry ... - Business Wire (press release)
www.businesswire.com - October 21 at 8:58 PM
Why High-Flying Aurinia Pharmaceuticals Stock Could Still Be Dirt Cheap - Motley FoolWhy High-Flying Aurinia Pharmaceuticals Stock Could Still Be Dirt Cheap - Motley Fool
www.fool.com - October 15 at 2:06 AM
Should You Buy Aurinia Pharmaceuticals Inc (AUPH)?Should You Buy Aurinia Pharmaceuticals Inc (AUPH)?
finance.yahoo.com - October 13 at 9:50 PM
Why High-Flying Aurinia Pharmaceuticals Stock Could Still Be Dirt CheapWhy High-Flying Aurinia Pharmaceuticals Stock Could Still Be Dirt Cheap
finance.yahoo.com - October 13 at 4:50 PM
Millennial investor mindful of Indigenous rights and climate change - The Globe and MailMillennial investor mindful of Indigenous rights and climate change - The Globe and Mail
www.theglobeandmail.com - October 7 at 4:51 PM
Research Initiated on Healthcare Stocks, Oncolytics Biotech, Aurinia Pharma, Immunovaccine, and IntelliPharmaCeutics InternationalResearch Initiated on Healthcare Stocks, Oncolytics Biotech, Aurinia Pharma, Immunovaccine, and IntelliPharmaCeutics International
finance.yahoo.com - October 3 at 3:57 PM
Aurinia Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : AUP-CA : September 29, 2017Aurinia Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : AUP-CA : September 29, 2017
finance.yahoo.com - October 2 at 4:07 PM
Aurinia Pharmaceuticals, Inc. – Value Analysis (TORONTO:AUP) : October 2, 2017Aurinia Pharmaceuticals, Inc. – Value Analysis (TORONTO:AUP) : October 2, 2017
finance.yahoo.com - October 2 at 4:07 PM
Aurinia Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : AUP-CA : September 13, 2017Aurinia Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : AUP-CA : September 13, 2017
finance.yahoo.com - September 13 at 5:25 PM
Aurinia Pharmaceuticals stock has tripled so far in 2017. Heres why that could be just the start. - Motley FoolAurinia Pharmaceuticals stock has tripled so far in 2017. Here's why that could be just the start. - Motley Fool
www.fool.com - September 2 at 8:54 PM
Aurinia Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : AUP-CA : September 1, 2017Aurinia Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : AUP-CA : September 1, 2017
finance.yahoo.com - September 1 at 4:45 PM
Too Many People Own StocksToo Many People Own Stocks
finance.yahoo.com - August 31 at 9:10 PM
Aurinia Pharmaceuticals Inc Expected to Earn FY2017 Earnings of ($1.27) Per Share (AUP)Aurinia Pharmaceuticals Inc Expected to Earn FY2017 Earnings of ($1.27) Per Share (AUP)
www.americanbankingnews.com - August 28 at 2:28 AM
3 Reasons to Buy Aurinia Pharmaceuticals Stock Right Now3 Reasons to Buy Aurinia Pharmaceuticals Stock Right Now
finance.yahoo.com - August 25 at 2:20 AM
Aurinia Pharmaceuticals, Inc. :AUP-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 15, 2017Aurinia Pharmaceuticals, Inc. :AUP-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 15, 2017
finance.yahoo.com - August 15 at 5:08 PM

SEC Filings

Isotechnika Pharma (TSE:AUP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Isotechnika Pharma (TSE AUP) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.